Description
GSK is seeking a VP, Oncology Clinical Development Disease Area Head, reporting to the SVP, Head of Oncology Clinical Development. You will lead and contribute to strategic clinical positioning of early- and late-phase assets across their life-cycle with a cross-functional matrix team.
Clinical Development Strategy & Portfolio Leadership You will be accountable for end-to-end clinical development of oncology assets from first-in-human studies through proof-of-concept studies, registrational trials, regulatory approval, and initial market launch.
Key Responsibilities:
- Shape and drive the scientific and clinical development strategy for assigned disease areas and assets.
- Ensure deep integration of clinical and disease-area expertise into preclinical and translational research activities.
- Evaluate, champion, and enable the use of novel approaches where they add clear scientific, operational, or decision-making value.
Program Oversight, Governance & Visibility
- Provide program-level oversight and leadership, while ensuring connectedness both cross-functionally and across assets.
- Serve as the senior clinical representative at key governance forums for assigned programs.
Cross-Functional Leadership & Connector Role
- Co-lead asset development with matrix leadership partners, driving alignment across research, development, and commercialization planning.
- Lead with an enterprise mindset, acting as a senior connector across functions.
People Leadership, Culture & Capability Building
- Line-manage and mentor Clinical Development Leads, Clinical Science Program Leads, Medical Directors, and Clinical Scientists.
- Foster a culture of empowerment, enterprise-level drug development, scientific excellence, inclusion, and collaboration.
Requirements:
- Medical degree with board certification or eligibility in oncology.
- At least 10 years clinical development experience leading global clinical development programs in hematology and oncology.
- Senior clinical and scientific leadership in early- and late-phase oncology drug development.
Preferred Qualifications:
- Clinical background in hematologic malignancies or hematology subspecialty.
- Strong ability to translate science and translational insight into differentiated clinical development strategies.
- Proven capability to operate as an enterprise drug developer at portfolio level.